Aro Biotherapeutics

Aro Biotherapeutics

Aro Biotherapeutics

Aro Biotherapeutics is focused on the development of a new protein drug platform called Centyrins, designed to achieve better efficacy and safety profiles for patients with cancer and other serious diseases.
Type
B2c
Founded
2017
Follow us
Alexa global traffic share
Team Size
1–10
Employees
https://www.inquirer.com

Philly-based gene-therapy drugmaker Aro Bio raises $88 million, will double staff